C WorldWide Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-196,598
Closed -$12.8M 94
2019
Q1
$12.8M Sell
196,598
-11,093
-5% -$737K 0.16% 33
2018
Q4
$13M Sell
207,691
-5,413
-3% -$378K 0.19% 30
2018
Q3
$16.5M Sell
213,104
-32,879
-13% -$2.48M 0.21% 29
2018
Q2
$17.4M Sell
245,983
-32,887
-12% -$2.32M 0.24% 28
2018
Q1
$21M Sell
278,870
-73,038
-21% -$5.81M 0.32% 25
2017
Q4
$25.2M Sell
351,908
-3,955,127
-92% -$300M 0.36% 26
2017
Q3
$349M Buy
4,307,035
+58,216
+1% +$4.45M 4.96% 8
2017
Q2
$301M Buy
4,248,819
+254,388
+6% +$16.9M 4.57% 11
2017
Q1
$271M Buy
3,994,431
+332,177
+9% +$23.4M 4.59% 10
2016
Q4
$262M Sell
3,662,254
-78,441
-2% -$5.83M 5.06% 7
2016
Q3
$296M Buy
3,740,695
+159,959
+4% +$13M 5.22% 6
2016
Q2
$299M Buy
3,580,736
+38,964
+1% +$3.46M 5.72% 8
2016
Q1
$325M Sell
3,541,772
-39,020
-1% -$3.52M 6.29% 5
2015
Q4
$362M Sell
3,580,792
-219,300
-6% -$22.8M 6.34% 3
2015
Q3
$373M Sell
3,800,092
-378,550
-9% -$42M 6.27% 3
2015
Q2
$489M Sell
4,178,642
-14,250
-0.3% -$1.56M 7% 2
2015
Q1
$411M Sell
4,192,892
-159,850
-4% -$16.2M 5.87% 5
2014
Q4
$410M Sell
4,352,742
-233,328
-5% -$24.1M 6.05% 5
2014
Q3
$488M Buy
+4,586,070
New +$449M 7.17% 3

Other funds holding GILD

C WorldWide Group's GILD Position: Q2 2019 in Review

C WorldWide Group sold out of Gilead Sciences (GILD) in Q2 2019, closing a stake of 196,598 shares — an estimated $12.8M sold.

C WorldWide Group first reported a position in GILD in Q3 2014 and held it in 19 quarters. The position peaked at $489M in Q2 2015. 1,483 funds tracked by Wall St. Rank hold GILD as of Q2 2019.

  • C WorldWide Group reported no remaining Gilead Sciences position as of Q2 2019 after selling out during the quarter.
  • C WorldWide Group sold 196,598 Gilead Sciences shares in Q2 2019, an estimated $12.8M.
  • C WorldWide Group first reported a position in Gilead Sciences in Q3 2014 and held it in 19 quarters.
  • C WorldWide Group's Gilead Sciences position peaked at $489M in Q2 2015.
  • 1,483 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2019.

Based on C WorldWide Group's 13F filing for Q2 2019, filed 2 Aug 2019.